Health411 - Sickle Cell Gene Editing Therapy
Manage episode 391250832 series 3236776
In this episode of Health411, host Dr. Jonathan Karp and producers Daniel Geller and Josh Brewer delve into the groundbreaking world of Casgevy, the first FDA-approved CRISPR/Cas9-based treatment for sickle cell anemia. They explore the science behind this revolutionary gene-editing therapy, its potential implications for patients, and the ethical considerations surrounding genetic interventions in healthcare.
250 епізодів